Remedee Labs’ Solution becomes the first CE marked medical device (class IIa) approved for the treatment of fibromyalgia in Europe
PARIS, Sept. 16, 2024 /PRNewswire/ — Remedee Labs, a French start-up that specializes in non-pharmacological treatments for chronic pain, is announcing today that it has obtained medical device status in Europe for its millimeter wave endorphin stimulator wristband. The Remedee Labs solution is now the first medical device clinically validated and certified in Europe to provide symptom relief for fibromyalgia, a disorder for which no specific treatment had previously been identified. This achievement marks a major advance in care for the millions of patients suffering from fibromyalgia.
